Picture of Immunocore Holdings logo

IMCR — Immunocore Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSucker Stock

Immunocore Holdings PLC expected to post a loss of 67  pence a share - Earnings Preview

* Immunocore Holdings PLC  IMCR.OQ   IMCR.O  is expected
to show a
rise in quarterly revenue when it reports  results on August
10. 
    * The Abingdon Oxfordshire-based  company is expected to
report  a
180.8% increase in revenue to £15.901 million from £5.66 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Immunocore Holdings
PLC
is for a loss of 67 pence per share. For the same quarter last
year, the company reported a loss of 74 pence per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Immunocore
Holdings PLC is $56​, above​ its last closing price of $54.40.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in pounds). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.82       -0.84      -0.37     Beat    56.2
 Dec. 31 2022  -0.80       -0.82      -0.91     Missed  -10.9
 Sep. 30 2021  -0.75       -0.63      -0.68     Missed  -8.1​
 Jun. 30 2021  -0.69       -0.68      -0.74     Missed  -7.8
 ​​Mar.        -0.59       -0.59      -0.66     Missed  -12.5
 31 2021                                                
 Dec. 31 2020  -0.76       -0.76      -0.62     Beat    22.4​
 This summary was machine generated August 8 at 07:32 GMT.  All
figures in pounds  unless otherwise stated

Recent news on Immunocore Holdings

See all news